Deborah Crouch

Array ( [id] => 3626122 [patent_doc_number] => 05602302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Models for asthma guinea pig' [patent_app_type] => 1 [patent_app_number] => 8/175740 [patent_app_country] => US [patent_app_date] => 1993-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2249 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602302.pdf [firstpage_image] =>[orig_patent_app_number] => 175740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692678 [patent_doc_number] => 05676924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'In vivo assay to determine cancer treatment effectiveness' [patent_app_type] => 1 [patent_app_number] => 8/169312 [patent_app_country] => US [patent_app_date] => 1993-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 3614 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/676/05676924.pdf [firstpage_image] =>[orig_patent_app_number] => 169312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4198804 [patent_doc_number] => 06013638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung' [patent_app_type] => 1 [patent_app_number] => 8/165753 [patent_app_country] => US [patent_app_date] => 1993-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 9223 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013638.pdf [firstpage_image] =>[orig_patent_app_number] => 165753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617184 [patent_doc_number] => 05641484 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen' [patent_app_type] => 1 [patent_app_number] => 8/162406 [patent_app_country] => US [patent_app_date] => 1993-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 54 [patent_no_of_words] => 28471 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641484.pdf [firstpage_image] =>[orig_patent_app_number] => 162406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700138 [patent_doc_number] => 05674703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Episomal vector systems and related methods' [patent_app_type] => 1 [patent_app_number] => 8/161286 [patent_app_country] => US [patent_app_date] => 1993-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10026 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674703.pdf [firstpage_image] =>[orig_patent_app_number] => 161286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3607659 [patent_doc_number] => 05589392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Nucleic acid construct encoding a nuclear transport peptide operatively linked to an inducible promoter' [patent_app_type] => 1 [patent_app_number] => 8/158718 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23231 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589392.pdf [firstpage_image] =>[orig_patent_app_number] => 158718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101214 [patent_doc_number] => 06066623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines' [patent_app_type] => 1 [patent_app_number] => 8/155888 [patent_app_country] => US [patent_app_date] => 1993-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9462 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066623.pdf [firstpage_image] =>[orig_patent_app_number] => 155888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528808 [patent_doc_number] => 05583020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Permeability enhancers for negatively charged polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/155474 [patent_app_country] => US [patent_app_date] => 1993-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 6881 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583020.pdf [firstpage_image] =>[orig_patent_app_number] => 155474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3680032 [patent_doc_number] => 05633076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Method of producing a transgenic bovine or transgenic bovine embryo' [patent_app_type] => 1 [patent_app_number] => 8/154019 [patent_app_country] => US [patent_app_date] => 1993-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 33697 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633076.pdf [firstpage_image] =>[orig_patent_app_number] => 154019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728859 [patent_doc_number] => 05652222 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/152621 [patent_app_country] => US [patent_app_date] => 1993-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 14651 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652222.pdf [firstpage_image] =>[orig_patent_app_number] => 152621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665220 [patent_doc_number] => 05625122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Mouse having a disrupted lck gene' [patent_app_type] => 1 [patent_app_number] => 8/145043 [patent_app_country] => US [patent_app_date] => 1993-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 32 [patent_no_of_words] => 5172 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625122.pdf [firstpage_image] =>[orig_patent_app_number] => 145043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665191 [patent_doc_number] => 05625121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Mice deficient in nerve growth factor receptors encoded by trkB' [patent_app_type] => 1 [patent_app_number] => 8/114859 [patent_app_country] => US [patent_app_date] => 1993-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 11383 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625121.pdf [firstpage_image] =>[orig_patent_app_number] => 114859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728179 [patent_doc_number] => 05670488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Adenovirus vector for gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/136742 [patent_app_country] => US [patent_app_date] => 1993-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 67 [patent_no_of_words] => 32462 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670488.pdf [firstpage_image] =>[orig_patent_app_number] => 136742 [rel_patent_id] =>[rel_patent_doc_number] =>)